New real-world studies show Vraylar boosts depression relief, functioning, and quality of life in MDD and bipolar I patients beyond clinical trials.
|Slideshows|May 7, 2020
5 Tips for Treating COVID-Related Anxiety
Author(s)Yujuan Choy, MD
A constellation of factors contributes to heightened anxiety symptoms associated with the pandemic. The author offers simple steps to help patients alleviate stress.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
Centanafadine For Comorbid ADHD and Anxiety: Talking New Data With John Kraus, MD, PhD
2
New Real-World Data Supporting Cariprazine for MDD and Bipolar I Depression
3
Brenipatide for Alcohol Use Disorder: Emerging Findings
4
Pimavanserin Linked to Fewer Falls Than Other Antipsychotics in Parkinson Disease Psychosis
5